Saito Biotech: Announcement on terminating the acquisition of 60% of the shares of Silver Valley Pharmaceutical Co., Ltd.
Shandong Sito Bio-technology: Announcement on the Release of Pledged Shares by Controlling Shareholders of the Company
Shandong Sito Bio-technology: Announcement regarding the transfer of 90.43% equity and debt exemption of overseas companies.
Shandong Sito Bio-technology: Announcement on the 2023 Profit Distribution Plan
Saito Biotech: “Asset Evaluation Report on the Asset Assessment Project for All Silver Valley Pharmaceutical Shareholders' Equity Value Assessment Project Involved in the Proposed Acquisition of Shares by Shandong Saito Biotechnology Co., Ltd.”
Saito Biotech: Announcement on the acquisition of 60% of the shares of Silver Valley Pharmaceutical Co., Ltd.
SETO Biotech: Reminder Notice on Issuing Shares to Specific Targets Using Simple Procedures to Lift Restrictions on Sale and Circulation
Saito Biotech: Announcement on the postponement of the repurchase of some of the shares pledged by the controlling shareholder of the company
Saito Biotech: Implementation Announcement on the Distribution of Equity for the Semiannual Year of 2023
Saito Biotech: Announcement on the 2023 Semi-Annual Profit Distribution Plan
Saito Biotech: Announcement on the Company\'s Deputy General Manager\'s Share Reduction Plan without reducing his holdings at the end of the period
Saito Biotech: 2022 Annual Equity Distribution Implementation Notice
Saito Biotech: Announcement on 2022 Profit Distribution Plan
Saito Biotech: Simplified Statement of Changes in Equity
Saito Biotech: Shandong Saito Biotechnology Co., Ltd. issued shares to specific targets using simple procedures and listed on the GEM issuance report
Saito Biotech: Prompt announcement on changes in the rights and interests of the company's controlling shareholders and their concerted actors
Saito Biotech: Report of Guojin Securities Co., Ltd. on the issuance process of Shandong Saito Biotechnology Co., Ltd. using simple procedures to issue shares to specific targets and listed shares on GEM and the compliance of subscribers
Saito Biotech: Guojin Securities Co., Ltd.'s listing sponsorship letter for Shandong Saito Biotechnology Co., Ltd. to issue shares to specific targets and be listed on the GEM in 2022
Saito Biotech: A listing announcement for Shandong Saito Biotechnology Co., Ltd. to issue shares to specific targets using simple procedures and listed on the GEM
Saito Biotech: Shandong Saito Biotechnology Co., Ltd. issued A-share stock prospectus to specific targets using simple procedures in 2022 (registration draft)
No Data
No Data